VIENNA, Va., May 29 /PRNewswire-FirstCall/ -- CEL-SCI Corporation
(Amex: CVM), a developer of cancer products, will present at Dutton
Associates' "Recognizing Opportunity" SmallCap Conference. Geert Kersten,
Chief Executive Officer, along with a select group of Dutton's top-followed
companies, will update investment professionals on business activities,
trends and current developments.
The conference will take place at The OMNI Hotel in San Francisco on
Wednesday, May 30 from 7:30 a.m. to 7 p.m. Mr. Kersten will make a
30-minute presentation in the morning, followed by a short Webcast
presentation (2 PM PST at http://www.jmdutton.com) and a 30-minute breakout
session with investors in the afternoon. The Web broadcast will be
available live on May 30, 2007 and thereafter at http://www.jmdutton.com.
During the day, Mr. Kersten will be available to meet with informal groups
of investment professionals during one-on-one scheduled meetings. For more
conference information and registration, visit http://www.jmdutton.com.
About CEL-SCI Corporation
CEL-SCI Corporation is developing new immune system based treatments
for cancer and infectious diseases. The Company has received the go-ahead
from the U.S. FDA and the Canadian Regulators to conduct a Phase III
clinical trial in advanced primary head and neck cancer patients with its
lead product Multikine(R). CEL-SCI's other products, which are currently in
pre-clinical stage and have been funded with U.S. government support, have
shown protection against a number of diseases in animal tests and are
currently being tested against diseases associated with bio-defense and
avian flu. The Company has operations in Vienna, Virginia and Baltimore,
Maryland.
About Dutton Associates
Dutton Associates, an international issuer-paid equity research firm,
offers independent, fundamental research on over 120 small-cap public
companies. Dutton's 29 analysts are primarily CFA charterholders with, on
average, over 20 years of experience at the major securities firms. For
more information, visit http://www.jmdutton.com.
SOURCE CEL-SCI Corporation
 back to top
Related links:
http://www.cel-sci.com
http://www.jmdutton.com
CONTACT:
Gavin de Windt of CEL-SCI Corporation,
+1-703-506-9460
|
